YU; Younong

Patent Applications and Registrations

Patent applications and USPTO patent grants for YU; Younong.The latest application filed is for "inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes".

Company Profile

2.43.67

YU; Younong - East Brunswick NJ
Yu; Younong - Rahway NJ
YU; Younong - Kenilworth NJ US
Yu; Younong - Piscataway NJ
Yu; Younong - Scotch Plains NJ
Yu, Younong - Picataway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Histone Deacetylase-3 Useful For The Treatment Of Cancer, Inflammation, Neurodegeneration Diseases And Diabetes App 20220177465 - LIU; Jian ; et al.	2022-06-09
4-amino Or 4-alkoxy-substituted Aryl Sulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20220000844 - Bungard; Christopher J. ; et al.	2022-01-06
Inhibitors Of Histone Deacetylase Useful For The Treatment Or Prevention Of Hiv Infection App 20210403479 - Yu; Wensheng ; et al.	2021-12-30
Substituted aminoquinazoline compounds as A.sub.2A antagonist Grant 10,822,338 - Ali , et al. November 3, 2	2020-11-03
Aminopyrazine compounds with A2A antagonist properties Grant 10,472,347 - Kuang , et al. Nov	2019-11-12
Processes for making substituted quinazoline compounds using hydrogen bonding catalysts Grant 10,392,353 - Chung , et al. A	2019-08-27
Indazole and azaindazole Btk inhibitors Grant 10,246,457 - Siu , et al.	2019-04-02
Substituted Aminoquinazoline Compounds As A2a Antagonist App 20180362530 - Ali; Amjad ; et al.	2018-12-20
Novel Processes For Making Substituted Quinazoline Compounds Using Hydrogen Bonding Catalysts App 20180346429 - Chung; Cheol K. ; et al.	2018-12-06
BTK inhibitors Grant 10,130,630 - Liu , et al. November 20, 2	2018-11-20
Aminopyrazine Compounds With A2a Antagonist Properties App 20180327385 - KUANG; Rongze ; et al.	2018-11-15
Factor XIa inhibitors Grant 10,093,683 - Lim , et al. October 9, 2	2018-10-09
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties Grant 10,011,615 - Ali , et al. July 3, 2	2018-07-03
Azacarbazole Btk Inhibitors App 20180141962 - LIU; JIAN ; et al.	2018-05-24
Indazole And Azaindazole Btk Inhibitors App 20180127411 - SIU; Tony ; et al.	2018-05-10
BTK inhibitors Grant 9,834,554 - Liu , et al. December 5, 2	2017-12-05
Btk Inhibitors App 20170340631 - LIU; JIAN ; et al.	2017-11-30
BTK Inhibitors Grant 9,718,828 - De Man , et al. August 1, 2	2017-08-01
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20170197991 - Ali; Amjad ; et al.	2017-07-13
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties Grant 9,676,780 - Ali , et al. June 13, 2	2017-06-13
FACTOR XIa INHIBITORS App 20170044183 - Lim; Yeon-Hee ; et al.	2017-02-16
Btk Inhibitors App 20170008899 - DE MAN; ADRIANUS PETRUS ANTONIUS ; et al.	2017-01-12
5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use Grant 9,499,502 - Wu , et al. November 22, 2	2016-11-22
Btk Inhibitors App 20160326164 - LIU; JIAN ; et al.	2016-11-10
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors Grant 9,481,682 - Kim , et al. November 1, 2	2016-11-01
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators Grant 9,469,615 - Boyce , et al. October 18, 2	2016-10-18
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use Grant 9,422,277 - Gilbert , et al. August 23, 2	2016-08-23
Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use Grant 9,416,129 - Gilbert , et al. August 16, 2	2016-08-16
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20160194330 - Ali; Amjad ; et al.	2016-07-07
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20150361098 - Ali; Amjad ; et al.	2015-12-17
Btk Inhibitors App 20150353570 - KIM; RONALD M. ; et al.	2015-12-10
Tricyclic Substituted Thiadiazine Dioxide Compounds As Bace Inhibitors, Compositions And Their Use App 20150284379 - Gilbert; Eric J. ; et al.	2015-10-08
Tricyclic Substituted Thiadiazine Dioxide Compounds As Bace Inhibitors, Compositions And Their Use App 20150274716 - Gilbert; Eric J. ; et al.	2015-10-01
Quinazolinone-type compounds as CRTH.sub.2 antagonists Grant 8,927,559 - Aslanian , et al. January 6, 2	2015-01-06
Btk Inhibitors App 20140221333 - De Man; Adrianus Petrus Antonius ; et al.	2014-08-07
Btk Inhibitors App 20140206681 - KIM; RONALD M. ; et al.	2014-07-24
5-substituted Iminothiazines And Their Mono- And Dioxides As Bace Inhibitors, Compositions, And Their Use App 20140128382 - Wu; Wen-Lian ; et al.	2014-05-08
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators App 20130303517 - Boyce; Christopher W. ; et al.	2013-11-14
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators Grant 8,569,312 - McCormick , et al. October 29, 2	2013-10-29
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators App 20130225582 - McCormick; Kevin D. ; et al.	2013-08-29
Quinazolinone-type Compounds As Crth2 Antagonists App 20130210805 - Aslanian; Robert G. ; et al.	2013-08-15
Functionally selective alpha2C adrenoreceptor agonists Grant 8,501,747 - de lera Ruiz , et al. August 6, 2	2013-08-06
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators Grant 8,476,274 - McCormick , et al. July 2, 2	2013-07-02
Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists Grant 8,470,863 - Zheng , et al. June 25, 2	2013-06-25
Reversed Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators App 20130079271 - McCormick; Kevin D. ; et al.	2013-03-28
Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators App 20130045914 - McCormick; Kevin D. ; et al.	2013-02-21
Crystalline polymorphs of a CXC-chemokine receptor ligand Grant 8,207,221 - Hu , et al. June 26, 2	2012-06-26
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators App 20110251207 - McCormick; Kevin D. ; et al.	2011-10-13
Functionally selective ALPHA2C adrenoreceptor agonists Grant 8,017,642 - Yu , et al. September 13, 2	2011-09-13
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands App 20110213029 - Taveras; Arthur G. ; et al.	2011-09-01
Functionally selective ALPHA2C adrenoreceptor agonists Grant 8,003,624 - McCormick , et al. August 23, 2	2011-08-23
Cyclopropylchromene Derivatives As Modulators Of The Alpha-2c Receptor App 20110190247 - Yu; Younong ; et al.	2011-08-04
ALPHA2C adrenoreceptor agonists Grant 7,985,748 - McCormick , et al. July 26, 2	2011-07-26
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,964,646 - Taveras , et al. June 21, 2	2011-06-21
Treatment of chemokine mediated diseases Grant 7,960,433 - Taveras , et al. June 14, 2	2011-06-14
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,947,720 - Taveras , et al. May 24, 2	2011-05-24
Thiadiazoles as CXC- and CC- chemokine receptor ligands Grant 7,786,149 - Biju , et al. August 31, 2	2010-08-31
Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100197562 - De lera Ruiz; Manuel ; et al.	2010-08-05
Alpha2c Adrenoreceptor Agonists App 20100173823 - McCormick; Kevin D. ; et al.	2010-07-08
Derivatives And Analogs Of Chroman As Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100168195 - Zheng; Junying ; et al.	2010-07-01
Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100144816 - McCormick; Kevin D. ; et al.	2010-06-10
.alpha.2C adrenoreceptor agonists Grant 7,700,592 - McCormick , et al. April 20, 2	2010-04-20
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands Grant 7,691,856 - Taveras , et al. April 6, 2	2010-04-06
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands Grant 7,671,212 - Taveras , et al. March 2, 2	2010-03-02
Phenoxypiperidines and analogs thereof useful as histamine H.sub.3 antagonists Grant 7,638,531 - Mutahi , et al. December 29, 2	2009-12-29
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands App 20090306079 - Taveras; Arthur G. ; et al.	2009-12-10
Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand App 20080279822 - Hu; Mengwei ; et al.	2008-11-13
Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands App 20080090823 - Biju; Purakkattle J. ; et al.	2008-04-17
Thiadiazoles AS CXC- and CC- chemokine receptor ligands Grant 7,338,968 - Biju , et al. March 4, 2	2008-03-04
Alpha2C adrenoreceptor agonists App 20080039439 - McCormick; Kevin D. ; et al.	2008-02-14
Functionally selective alpha2C adrenoreceptor agonists App 20080027100 - McCormick; Kevin D. ; et al.	2008-01-31
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands App 20070264230 - Taveras; Arthur G. ; et al.	2007-11-15
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists App 20070167435 - Mutahi; Mwangi W. ; et al.	2007-07-19
Treatment of chemokine mediated diseases App 20070155756 - Taveras; Arthur G. ; et al.	2007-07-05
Alpha2C adrenoreceptor agonists App 20070093477 - McCormick; Kevin D. ; et al.	2007-04-26
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20070021494 - Taveras; Arthur G. ; et al.	2007-01-25
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,132,445 - Taveras , et al. November 7, 2	2006-11-07
Thiadiazoles AS CXC- and CC- chemokine receptor ligands App 20060223864 - Biju; Purakkattle J. ; et al.	2006-10-05
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands App 20060025453 - Taveras; Arthur G. ; et al.	2006-02-02
Crystalline polymorphs of a CXC-chemokine receptor ligand App 20050192345 - Hu, Mengwei ; et al.	2005-09-01
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists Grant 6,878,709 - Taveras , et al. April 12, 2	2005-04-12
Heterocyclic cytotoxic agents App 20050009830 - LaVoie, Edmond J. ; et al.	2005-01-13
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands App 20040186142 - Taveras, Arthur G. ; et al.	2004-09-23
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040147559 - Taveras, Arthur G. ; et al.	2004-07-29
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040106794 - Taveras, Arthur G. ; et al.	2004-06-03
Heterocyclic cytotoxic agents Grant 6,740,650 - LaVoie , et al. May 25, 2	2004-05-25
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040097547 - Taveras, Arthur G. ; et al.	2004-05-20
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists App 20040063709 - Taveras, Arthur G. ; et al.	2004-04-01
Treatment of chemokine mediated diseases App 20040053953 - Taveras, Arthur G. ; et al.	2004-03-18
Heterocyclic cytotoxic agents App 20030100560 - LaVoie, Edmond J. ; et al.	2003-05-29